New Therapies for Rare Bone Disease (On Demand)
Activity approved for 1.00 ASRT Category A Credits
Activity approved for up to 1.0 AMA PRA Category 1 Credits™
Activity Expires October 1, 2024
Attendees will learn how to diagnose and manage rare bone diseases such as hypophosphatemic rickets and hypophosphatasia. Attendees can listen to a clear lecture and understand the state of the art of how to diagnose and manage rare bone diseases such as hypophosphatemic rickets and hypophosphatasia.
1. The attendee will understand how to diagnose and manage hypophosphatemic rickets
2. The attendee will understand how to diagnose and manage hypophosphatasia
3. The attendee will understand how to diagnose and manage osteogenesis imperfecta
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
On-Demand/ Enduring Material Cancellation Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
ACCME Accreditation Statement
The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at firstname.lastname@example.org.
AMA PRA Category 1 Credit(s)™
The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.00 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on September 1, 2023, and will expire on October 1, 2024.
Manju Chandran, MD, FACP, FACE, FAMS
Senior Consultant and Director
Singapore General Hospital
Dr Manju Chandran is a Senior Consultant Endocrinologist and Director of the Osteoporosis and Bone Metabolism Unit at Singapore General Hospital (SGH).
She is the Chairperson of the Asia Pacific Consortium on Osteoporosis (APCO), past Chairperson of the Chapter of Endocrinologists, College of Physicians, Academy of Medicine, Singapore; elected Member of the Council of Scientific Advisors and Board Member of the IOF and Deputy Chair of its Asia Pacific Regional Advisory Council; Past President of the Endocrine and Metabolic Society of Singapore, Vice Chair of the Asia Pacific Panel of the ISCD, and Treasurer of the Osteoporosis Society of Singapore. She was a Member of the Publications Committee of the ASBMR and current member of its Women In Bone and Mineral Research Committee. She has won a multitude of international awards, including the most prestigious of the IOF awards- the 2021 Olof Johnell Science Award, the IOF Committee of National Societies Medal 2015; the IOF International Young Investigator Award 2013, the SGH Most Inspiring Mentor Award 2021 and the Singhealth DUKE NUS Most Caffeinated Researcher Award 2020. OPTIMAL- the Secondary Fracture Prevention and Fracture Liaison Service she set up at SGH was the 3rd in the world and the 1st in the Asia Pacific to win the Gold Star in the IOF’s Capture the Fracture Global Map of Best Practice in 2015.
Her research and clinical interests include the epidemiology and health economic burden of osteoporosis, rare bone disorders, diabetes and bone health and parathyroid disorders. She has close to160 publications more than ¾ of which she is the first or senior author of. She is the Section Co-Editor on Osteoporosis in the ASBMR's Primer on Metabolic Bone Diseases. She is a regular Keynote, Plenary and Symposium speaker at regional and international conferences in the fields of Endocrinology and Bone Metabolism.
Disclosure(s): No financial relationships to disclose
Course Planners and Managers
Fiore Barbini - No Financial Relationships to Disclose
Jill Seely, BS, CAHI, CMA - No Financial Relationships to Disclose
Harold Rosen, MD, CCD - No Financial Relationships to Disclose
Course Content Reviewers
Wendy Tolman-Andrews - No Financial Relationships to Disclose
Manju Chandran, MD, FACP, FACE, FAMS- No Financial Relationships to Disclose
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to email@example.com. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
|Access Date||Quiz Result||Score||Actions|